Lipid perodixation of lung surfactant by bacteria

Lung

Volumn 177, Issue 2, 1999, Pages 101-110

  Bouhafs, Rabea K L ^a   Jarstrand, C ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bacteria; Lipid perodixation; Reactive oxygen radicals; Surfactant

Indexed keywords

LUNG SURFACTANT; ALPHA TOCOPHEROL; FREE RADICAL; REACTIVE OXYGEN METABOLITE;

ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; ESCHERICHIA COLI; HOST RESISTANCE; HUMAN; LIPID PEROXIDATION; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS SURFACE TENSION; LUNG INFECTION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEPTICEMIA; STREPTOCOCCUS AGALACTIAE; BACTERIAL PNEUMONIA; DRUG EFFECT; LUNG; METABOLISM; MICROBIOLOGY; NEWBORN; PATHOGENICITY; PHYSIOLOGY; VIRULENCE;

ESCHERICHIA COLI; FREE RADICALS; HUMANS; INFANT, NEWBORN; LIPID PEROXIDATION; LUNG; PNEUMONIA, BACTERIAL; PSEUDOMONAS AERUGINOSA; PULMONARY SURFACTANTS; REACTIVE OXYGEN SPECIES; STREPTOCOCCUS AGALACTIAE; VIRULENCE; VITAMIN E;

EID: 0032618574     PISSN: 03412040     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00007629     Document Type: Article

References (47)

1. Ashkar S, Binkley F, Jones DP (1981) Resolution of a renal sullhydryl (glutathione) oxidase from γ-glutamyltransferase. FEBS Lett 124: 166-168
2. Auten RL, Notter RH, Kendig JW, Davis JM, Shapiro DL (1991) Surfactant treatment of full term newborns with respiratory failure. Pediatrics 87: 101-107
3. Avery ME, Mead J (1959) Surface properties in relation to atelectasis and hyaline membrane disease. Am J Dis Child 97;517-523
4. Baehner RL (1975) Subcellular distribution of nitroblue tetrazolium reductase (NBT-R) in human polymorphonuclear leukocytes (PMN). J Lab Clin Med 86: 785-792
5. Bannister JV, Bannister WH, Rotilio G (1987) Aspects of the structure, function, and applications of superoxide dismutase. Crit Rev Biochem 22: 111-180
6. Benedetti A, Casini AF, Ferrali M (1977) Red cell lysis coupled to the peroxidation of liver microsomal lipids: compartmentalization of the hemolytic system. Res Commun Chem Pathol Pharmacol 17: 519-528
7. Benedetti A, Casini AF, Ferrali M, et al. (1979) Effects of diffusable products of peroxidation of rat liver microsomal lipid. Biochem J 180: 303-312
8. Boyd RF (1984) Prokaryotic ultrastructure and function. In: General Microbiology (eds) Times Mirror/Mosby, St. Louis, MO, pp 153-299
9. Briggs RT, Drath DB, Karnovsky ML, Karnovsky MJ (1975) Localisation of NADH oxidase on the surface of human polymorphonuclear leukocytes by a new cytochemical method. J Cell Biol 67: 566-586
10. Brogden KA (1992) Ovine pulmonary surfactant induces killing of Pasteurella haemolytica, Escherichia coli, and Klebsiella pneumoniae by normal serum. Infect Immun 60: 5182-5189
11. Brogden KA, Cutlip RC, Lehmkuhl HD (1986) Complexing of bacterial lipopolysaccharide with lung surfactant. Infect Immun 52: 644-649
12. Collaborative Europeart Multicenter Study Group (1988) Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Pediatrics 82;683-691
13. Coonrod JD, Yoneda K (1983) Detection and partial characterization of antibacterial factor(s) in alveolar lining material of rats. J Clin Invest 71: 129-141
14. Eidus L, Diena BB, Greenberg L (1959) Observation of the use of tetrazolium salts in vital staining of bacteria. Can J Microbiol 5: 245-250
15. Fujiwara T, Maeta H, Chida S, Watabe Y, Abe T (1980) Artificial surfactant therapy in hyaline membrane disease. Lancet 1: 55-59
16. Furst P (1996) The role of antioxidants in nutritional support. Proc Nutr Soc 55: 945-961
17. Gray BM, Pritchard DG (1992) Phase variation in the pathogenesis of group B streptococcal infections: new perspectives on streptococcal infections. (Suppl 22): 452-454
18. Hallman M, Spragg R, Harrell JH, Moser KM, Gluck L (1982) Evidence of lung surfactant abnormality in respiratory failure: study of bronchoalveolar lavage phospholipids, surface activity and plasma myoinositol. J Clin Invest 70: 673-683
19. Herting E, Harms K, Speer CP, and members of the Collaborative European Multicenter Study Group (1991) Incidence of neonatal infections in very low birth weight infants with severe RDS treated with a natural porcine surfactant. Biol Neonate 59: 382-383 (abstr)
20. Herting E, Jarstrand C, Rasool O, Curstedt T, Sun B, Robertson B (1994) Experimental neonatal group B streptococcal pneumonia: effect of a modified porcine surfactant on bacterial proliferation in ventilated near-term rabbits. Pediatr Res 6: 784-791
21. Herting E, Strayer DS, Jarstrand C, Sun B, Robertson B (1998) Lung function and bacterial proliferation in experimental neonatal pneumonia in ventilated rabbits exposed to monoclonal antibody to surfactant protein A. Lung 176: 123-131
22. Herting E, Sun B, Jarstrand C, Curstedt T, Robertson B (1997) Surfactant improves lung function and mitigates bacterial growth in immature ventilated rabbits with experimental neonatal group B streptococcal pneumonia. Arch Dis Child 76: F3-F8
23. Hruszkewycz AM, Glende EA, Recknagel RO (1978) Destruction of microsomal cytochrome P-450 and glucose-6-phosphatase by lipids extracted from peroxidized microsomes. Toxicol Appl Pharmacol 46: 695-702
24. Jarstrand C, Berggren P, Curstedt T, Johansson A, Robertson B, Wiernik A (1984) Influence of lung surfactant phospholipids on neutrophilic granulocytes and blood monocytes. Prog Respir Res 18: 44-50
25. Jarstrand C, Wiernik A, Curstedt T, Sundqvist KG (1991) Lung surfactant inhibits the lipopolysaccha-ride-induced release of oxygen radicals, enzymes and interleukin-1 from phagocytes. Immun Infect Dis 1: 179-182
26. Jobe A, Ikegami M (1987) Surfactant for the treatment of respiratory distress syndrome. Am Rev Respir Dis 136: 1256-1275
27. LaForce FM, Boose DS (1981) Sublethal damage of Escherichia coli by lung lavage. Am Rev Respir Dis 124: 733-737
28. LaForce FM, Boose DS (1984) Effect of zinc and phosphate on an antibacterial peptide isolated from lung lavage. Infect Immun 45: 692-696
29. Lehrer RI, Selsted ME, Szklarek D, Fleichmann J (1983) Antibacterial activity of microbicidal cationic proteins 1 and 2, natural peptide antibiotics of rabbit lung macrophages. Infect Immun 42: 10-14
30. Lotze A, Knight GR, Martin GR, Bulas DI, Hull WM, O'Donnell RM, Whitsett JA, Short BL (1993) Improved pulmonary outcome after exogenous surfactant therapy for respiratory failure in term infants requiring extracorporeal membrane oxygenation. J Pediatr 122: 261-268
31. MacDonald JT, Maheswaran SK, Opuda-Asibo J, Townsend EL, Thies ES (1983) Susceptibility of Pasteurella haemolytica to the bactericidal effects of serum, nasal secretions and bronchoalveolar washings from cattle. Vet Sci 8: 585-599
32. May PS, Winter JW, Fried GH, Antopol W (1960) Effect of tetrazolium salts on selected bacterial species. Proc Soc Exp Biol Med 105: 364-366
33. McArthur H, Ceri H (1983) Interaction of a rat lung lectine with the polysaccharides of Pseudomonas aeruginosa. Infect Immun 42: 574-578
34. Miller RA, Britigan BE (1997) Role of oxidants in microbial pathophysiology. Clin Microbiol Rev 1: 1-18
35. Murray PR, Kobayashi GS, Pfaller MA, Rosenthal KS (1994) Bacteriology. In: Farrell R (ed) Medical Microbiology. Mosby, St Louis, MO, pp 188, 231-233, 253-258
36. Neumeister B, Woerndle S, Bartmann P (1996) Effect of different surfactant preparations on bacterial growth in vitro. Biol Neonate 70: 128-134
37. Oldham KT, Guice KS, Stetson PS, Wolfe RR (1989) Bacteremia-induced suppression of alveolar surfactant production. J Surg Res 47: 397-402
38. Pison U, Max M, Neuendank A, Weissbach S, Pietschmann S (1994) Host detente capacities of pulmonary surfactant: evidence for "non-surfactant" functions of the surfactant system. Eur J Clin Invest 24: 586-599
39. Sherman M, D'Ambola AE, Barrett CT (1988) Surfactant therapy of newborn rabbits impairs lung macrophage bactericidal activity. J Appl Physiol 65: 137-145
40. Sherman MP, Campbell LA, Merritt TA, Long WA, Gunkel JH, Curstedt T, Robertson B (1994) Effect of three different surfactants on pulmonary group B streptococcal infection in premature rabbits. J Pediatr 125: 939-947
41. Sherman MP, Campbell LA, Merritt TA, Shapiro DL, Long WA, Gunkel JH (1990) The infected preterm rabbit lung. In: von Wichert P, Muller B (eds) Basic Research on Lung Surfactant. Basel, Karger, pp 204-208
42. Sies H (1985) Hydroperoxides and thiol oxidants in the study of oxidative stress in intact cells and organs. In: Sies H (ed) Oxidative Stress, Academic Press, London, UK, pp 73-90
43. Speer CP, Götze B, Curstedt T, Robertson B (1991) Phagocytic function and TNF secretion of human monocytes exposed to natural porcine surfactant (Curosurf). Pediatr Res 30: 69-74
44. Speer CP, Robertson B, Custedt T, Halliday HL, Compagnone D, Gefeller O, Herting E, et al. (1992) Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf. Pediatrics 89: 13-20
45. Tribble DL, Tak YA, Jones DP (1987) The pathophysiological significance of lipid peroxidation in oxidative cell injury. Hepatology 2: 377-387
46. Ueda K, Kobayashi S, Morita J, et al. (1985) Site-specific damage caused by lipid peroxidation products. Biochim Biophys Acta 824: 341-348
47. Urban T, Jarstrand C (1979) Nitroblue tetrazolium reduction by bacteria. Acta Pathol Microbiol Scand Sect B 87: 227-233